Beliz Bahar Karaoğlan/LinkedIn
Nov 3, 2024, 12:38
Beliz Bahar Karaoğlan: Is 3 months of adjuvant chemo enough for all low-risk stage III colon cancer patients?
Beliz Bahar Karaoğlan, Medical Oncology Fellow at Ankara University, shared on X about recent paper by her as first author, titled “Adjuvant Chemotherapy Duration and Disease-Free Survival in Low-Risk Stage III Colon Cancer with N1a-b and N1c Disease: Insights from a Single-Center Retrospective Analysis” published on Springer Nature Link.
Authors: Beliz Bahar Karaoğlan, İremsu Öztürk, Cihangir Akyol, Berna Savaş, Güngör Utkan
“Is 3 months of adjuvant chemo enough for all low-risk stage III colon cancer patients? Our new study highlights the need for 6 months of chemo in patients with tumor deposits, specifically pT1-3N1c (without LN metastases).”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 05:05
Dec 22, 2024, 04:53
Dec 22, 2024, 04:52